RAYZEBIO, INC.
Profile
Company Names
RAYZEBIO, INC.
Addresses
5505 MOREHOUSE DRIVE, SUITE 300, SAN DIEGO, CA 92121
9880 CAMPUS POINT DR., SUITE 410, SAN DIEGO, CA 92121
Phone Numbers
(619) 937-2754
4154125509
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2020
State Incorporated:
DELAWARE
Total Amount Raised:
$396,432,007.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2022-08-25
$167,901,481.00
$167,901,481.00
$0.00
Equity
3
2021-06-08
$108,530,514.00
$108,530,514.00
$0.00
Equity
2
2020-11-23
$105,000,012.00
$105,000,012.00
$0.00
Equity
1
2020-08-05
$15,000,000.00
$45,000,000.00
$30,000,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEREL
DAVIS
DIRECTOR
CHANRX CORP.
| LAGUNA PHARMACEUTICALS, INC.
| INCEPTION IBD, INC.
| TRAVUS THERAPEUTICS, INC.
| VERSANT VENTURE CAPITAL VI, L.P.
| MISTRAL THERAPEUTICS, INC.
| VERSANT VOYAGEURS I FEEDER, L.P.
| VERSANT VENTURE CAPITAL VII, L.P.
| TURNSTONE BIOLOGICS CORP.
| NORTHERN MOSAIC LP
| VERSANT VOYAGEURS I, L.P.
| VERSANT VOYAGEURS I PARALLEL, L.P.
| CHINOOK THERAPEUTICS U.S., INC.
| VENTUS THERAPEUTICS U.S., INC.
| TENTARIX BIOTHERAPEUTICS, LP
| RAYZEBIO, INC.
| GRAPHITE BIO, INC.
| VERSANT VANTAGE II, L.P.
| VERSANT VOYAGEURS II, L.P.
| VERSANT VOYAGEURS II (CANADA), L.P.
| VERSANT VENTURE CAPITAL VIII, L.P.
| VERSANT VENTURE CAPITAL VIII (CANADA), L.P.
| SANTA ANA BIO, INC.
| VERSANT VOYAGEURS III, L.P.
| VERSANT VOYAGEURS III (CANADA), L.P.
| VERSANT VANTAGE III, L.P.
| VERSANT VANTAGE III (CANADA), L.P.
| VERSANT VENTURE CAPITAL IX, L.P.
| VERSANT VENTURE CAPITAL IX (CANADA), L.P.
| FIREFLY BIO, INC.
| VERSANT VENTURE CAPITAL SPV I (SAB), L.P.
AARON
KANTOFF
DIRECTOR
MAHA
KATABI
DIRECTOR
EFFECTOR THERAPEUTICS, INC.
| APELLIS PHARMACEUTICALS, INC.
| AEROVATE THERAPEUTICS, INC.
| VERA THERAPEUTICS, INC.
| GYROSCOPE THERAPEUTICS LTD
| QUANTA THERAPEUTICS, INC.
| SOFINNOVA VENTURE PARTNERS XI, L.P.
| RAYZEBIO, INC.
| MAREA THERAPEUTICS, INC.
| SOFINNOVA VENTURE PARTNERS XII, L.P.
| STAR THERAPEUTICS LLC
BONG
KOH
DIRECTOR
ALEX
ROSEN
DIRECTOR
AARON
ROYSTON
DIRECTOR
IMPEL NEUROPHARMA INC
| MENLO THERAPEUTICS, INC.
| HARMONY BIOSCIENCES II, INC.
| AKERO THERAPEUTICS, INC.
| VENBIO GLOBAL STRATEGIC FUND III, L.P.
| SWIFT HEALTH SYSTEMS INC.
| RAYZEBIO, INC.
| VENBIO GLOBAL STRATEGIC FUND IV, L.P.
| VENTYX BIOSCIENCES, INC.
| NEUROGASTRX, INC.
| MAREA THERAPEUTICS, INC.
| VENBIO GLOBAL STRATEGIC FUND V, L.P.
| ARPEGGIO BIOSCIENCES, INC.
| CALDERA THERAPEUTICS, INC.
ANGIE
YOU
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-08-25
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

